Interpol To Help Stop Trade Of Counterfeit Antiretroviral, TB, Malaria Drugs In Africa
Main Category: TuberculosisAlso Included In: HIV / AIDS; Pharmacy / Pharmacist
Article Date: 09 Nov 2007 - 12:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Health Professional: | ![]() |
5 (1 votes) |
| Article Opinions: | 0 posts |
The international police agency Interpol later this year plans to join the fight to stop the growing trade of counterfeit antiretroviral, tuberculosis and malaria drugs in Africa, John Newton, manager of Interpol's intellectual property rights project, said Tuesday at the agency's 76th General Assembly in Marrakech, Morocco, AFP/Yahoo! Health reports.
Representatives from Congo, Nigeria, Senegal and Sudan asked the 186-member police body at the assembly for assistance in preventing smuggling networks from making counterfeit drugs available in their markets and pharmacies, Newton said. Interpol plans to train police in African countries on how to eliminate counterfeit drug smuggling networks, coordinate police operations and track the trade of fake medicines from other parts of the world to the continent. Interpol also will collaborate with the World Health Organization and pharmaceutical companies to address the problem, Newton said.
"We are concerned about counterfeit medicines for life-threatening diseases such as malaria, TB and HIV/AIDS and increasingly getting involved in this area," Newton said. He added that the agency hopes to build on its successes in Latin America and Southeast Asia. "We have learned a lot of lessons in those regions and we are now able to apply those to Africa," he said, adding, "We can bridge the gap between law enforcement and the public health sector; we are able to bring the two areas together."
WHO estimates that up to 30% of the medicine sold in Africa is counterfeit. Interpol in 2005 conducted its first investigation of the counterfeit drug trade in seven Southeast Asian countries. The Center for Medicines in the Public Interest estimates that global counterfeit drug sales will rise to $75 billion by 2010, a 90% increase from 2005 (AFP/Yahoo! Health, 11/6).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |






